Your browser doesn't support javascript.
loading
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.
Liu, Yuying; Zhou, Nannan; Zhou, Li; Wang, Jing; Zhou, Yabo; Zhang, Tianzhen; Fang, Yi; Deng, Jinwei; Gao, Yunfeng; Liang, Xiaoyu; Lv, Jiadi; Wang, Zhenfeng; Xie, Jing; Xue, Yuanbo; Zhang, Huafeng; Ma, Jingwei; Tang, Ke; Fang, Yiliang; Cheng, Feiran; Zhang, Chengjuan; Dong, Bing; Zhao, Yuzhou; Yuan, Peng; Gao, Quanli; Zhang, Haizeng; Xiao-Feng Qin, F; Huang, Bo.
Afiliação
  • Liu Y; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Zhou N; Clinical Immunology Center, CAMS, Beijing, China.
  • Zhou L; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Wang J; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Zhou Y; National Cancer Center/Cancer Hospital, CAMS, Beijing, China.
  • Zhang T; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Fang Y; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Deng J; National Cancer Center/Cancer Hospital, CAMS, Beijing, China.
  • Gao Y; Weifang Hospital of Traditional Chinese Medicine, Weifang, China.
  • Liang X; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Lv J; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Wang Z; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Xie J; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Xue Y; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Zhang H; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Ma J; Cancer Hospital of Yunnan Province, Kunming, China.
  • Tang K; Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
  • Fang Y; Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
  • Cheng F; Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
  • Zhang C; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Dong B; Department of Immunology & National Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College, Beijing, China.
  • Zhao Y; Center of Bio repository, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Yuan P; Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, China.
  • Gao Q; Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Zhang H; Department of Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Xiao-Feng Qin F; Department of Breast Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Huang B; Department of Immunology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
Nat Immunol ; 22(3): 358-369, 2021 03.
Article em En | MEDLINE | ID: mdl-33432230
CD8+ T cell exhaustion dampens antitumor immunity. Although several transcription factors have been identified that regulate T cell exhaustion, the molecular mechanisms by which CD8+ T cells are triggered to enter an exhausted state remain unclear. Here, we show that interleukin-2 (IL-2) acts as an environmental cue to induce CD8+ T cell exhaustion within tumor microenvironments. We find that a continuously high level of IL-2 leads to the persistent activation of STAT5 in CD8+ T cells, which in turn induces strong expression of tryptophan hydroxylase 1, thus catalyzing the conversion to tryptophan to 5-hydroxytryptophan (5-HTP). 5-HTP subsequently activates AhR nuclear translocation, causing a coordinated upregulation of inhibitory receptors and downregulation of cytokine and effector-molecule production, thereby rendering T cells dysfunctional in the tumor microenvironment. This molecular pathway is not only present in mouse tumor models but is also observed in people with cancer, identifying IL-2 as a novel inducer of T cell exhaustion.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Interleucina-2 / Receptores de Hidrocarboneto Arílico / Linfócitos T CD8-Positivos / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Microambiente Tumoral / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos do Interstício Tumoral / Interleucina-2 / Receptores de Hidrocarboneto Arílico / Linfócitos T CD8-Positivos / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Microambiente Tumoral / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article